These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 36702811

  • 21. Multiple types of human papillomavirus infection and anal precancerous lesions in HIV-infected men in Taiwan: a cross-sectional study.
    Cheng SH, Liao KS, Wang CC, Cheng CY, Chu FY.
    BMJ Open; 2018 Jan 27; 8(1):e019894. PubMed ID: 29374678
    [Abstract] [Full Text] [Related]

  • 22. Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers.
    Dehlendorff C, Baandrup L, Kjaer SK.
    J Natl Cancer Inst; 2021 Jul 01; 113(7):869-874. PubMed ID: 33377930
    [Abstract] [Full Text] [Related]

  • 23. Human Papillomavirus infection and cervical lesions in HIV infected women on antiretroviral treatment in Thailand.
    Delory T, Ngo-Giang-Huong N, Rangdaeng S, Chotivanich N, Limtrakul A, Putiyanun C, Suriyachai P, Matanasarawut W, Jarupanich T, Liampongsabuddhi P, Heard I, Jourdain G, Lallemant M, Le Coeur S, PapilloV study group.
    J Infect; 2017 May 01; 74(5):501-511. PubMed ID: 28254419
    [Abstract] [Full Text] [Related]

  • 24. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
    Ndizeye Z, Vanden Broeck D, Lebelo RL, Bogers J, Benoy I, Van Geertruyden JP.
    PLoS One; 2019 May 01; 14(6):e0209303. PubMed ID: 31237894
    [Abstract] [Full Text] [Related]

  • 25. Human papillomavirus, cancer and vaccination.
    Heard I.
    Curr Opin HIV AIDS; 2011 Jul 01; 6(4):297-302. PubMed ID: 21519247
    [Abstract] [Full Text] [Related]

  • 26. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana.
    Firnhaber C, Evans D, Friedman-Khalili R, Willliams S, Michelow P, Matlhagela K, Wester C, Grinsztejn B, Lockman S.
    J Clin Virol; 2011 Nov 01; 52(3):265-8. PubMed ID: 21908233
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
    Uberti-Foppa C, Origoni M, Maillard M, Ferrari D, Ciuffreda D, Mastrorilli E, Lazzarin A, Lillo F.
    J Med Virol; 1998 Oct 01; 56(2):133-7. PubMed ID: 9746069
    [Abstract] [Full Text] [Related]

  • 28. High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa.
    Chachage M, Parikh AP, Mahenge A, Bahemana E, Mnkai J, Mbuya W, Mcharo R, Maganga L, Mwamwaja J, Gervas R, Kibuuka H, Maswai J, Singoei V, Iroezindu M, Fasina A, Esber A, Dear N, Imbach M, Crowell TA, Hern J, Song X, Hoelscher M, Polyak CS, Ake JA, Geldmacher C, AFRICOS Study Group.
    AIDS; 2023 Mar 15; 37(4):625-635. PubMed ID: 36398743
    [Abstract] [Full Text] [Related]

  • 29. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus.
    Palefsky JM, Lensing SY, Belzer M, Lee J, Gaur AH, Mayer K, Futterman D, Stier EA, Paul ME, Chiao EY, Reirden D, Goldstone SE, Tirado M, Cachay ER, Barroso LF, Da Costa M, Darragh TM, Rudy BJ, Wilson CM, Kahn JA.
    Clin Infect Dis; 2021 Oct 20; 73(8):1388-1396. PubMed ID: 33991185
    [Abstract] [Full Text] [Related]

  • 30. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F, Yan P, Huang X, Wang C, Du H, Qu X, Wu R.
    BMC Cancer; 2022 Jan 06; 22(1):42. PubMed ID: 34991494
    [Abstract] [Full Text] [Related]

  • 31. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT, Min KJ, Cho HW, Ki M, Oh JK, Shin SY, Hong JH, Lee JK.
    J Gynecol Oncol; 2018 Jan 06; 29(1):e14. PubMed ID: 29185272
    [Abstract] [Full Text] [Related]

  • 32. Characteristics of HPV infection over time in European women who are HIV-1 positive.
    Heard I, Cubie HA, Mesher D, Sasieni P, MACH-1 Study Group.
    BJOG; 2013 Jan 06; 120(1):41-9. PubMed ID: 23121095
    [Abstract] [Full Text] [Related]

  • 33. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus.
    Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM.
    Arch Pediatr Adolesc Med; 2000 Feb 06; 154(2):127-34. PubMed ID: 10665598
    [Abstract] [Full Text] [Related]

  • 34. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.
    Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E.
    Int J Cancer; 2003 Oct 10; 106(6):896-904. PubMed ID: 12918067
    [Abstract] [Full Text] [Related]

  • 35. The vaginal microbiota of women living with HIV on suppressive antiretroviral therapy and its relation to high-risk human papillomavirus infection.
    Chávez-Torres M, Gómez-Palacio-Schjetnan M, Reyes-Terán G, Briceño O, Ávila-Ríos S, Romero-Mora KA, Pinto-Cardoso S.
    BMC Microbiol; 2023 Jan 19; 23(1):21. PubMed ID: 36658503
    [Abstract] [Full Text] [Related]

  • 36. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
    Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, Hall C, Bacon M, Levine AM, Watts DH, Silverberg MJ, Xue X, Schlecht NF, Melnick S, Palefsky JM.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):577-86. PubMed ID: 15840880
    [Abstract] [Full Text] [Related]

  • 37. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
    Wang Q, Ma X, Zhang X, Ong JJ, Jing J, Zhang L, Wang LH.
    Sex Transm Infect; 2019 Mar 20; 95(2):140-144. PubMed ID: 30337414
    [Abstract] [Full Text] [Related]

  • 38. Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV/AIDS: effect of anti-retroviral therapy.
    Kelly HA, Sawadogo B, Chikandiwa A, Segondy M, Gilham C, Lompo O, Omar T, Didelot MN, Nagot N, Meda N, Weiss HA, Delany-Moretlwe S, Mayaud P, HARP Study Group.
    AIDS; 2017 Jan 14; 31(2):273-285. PubMed ID: 27755107
    [Abstract] [Full Text] [Related]

  • 39. Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.
    Kojic EM, Kang M, Cespedes MS, Umbleja T, Godfrey C, Allen RT, Firnhaber C, Grinsztejn B, Palefsky JM, Webster-Cyriaque JY, Saah A, Aberg JA, Cu-Uvin S.
    Clin Infect Dis; 2014 Jul 01; 59(1):127-35. PubMed ID: 24723284
    [Abstract] [Full Text] [Related]

  • 40. HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine.
    Money DM, Moses E, Blitz S, Vandriel SM, Lipsky N, Walmsley SL, Loutfy M, Trottier S, Smaill F, Yudin MH, Klein M, Harris M, Cohen J, Wobeser W, Bitnun A, Lapointe N, Samson L, Brophy J, Karatzios C, Ogilvie G, Coutlée F, Raboud J, HPV in HIV Study Group.
    Vaccine; 2016 Sep 14; 34(40):4799-806. PubMed ID: 27544584
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.